UNC-2025 is a novel potent and highly orally bioavailable Mer/FLT3 dual inhibitor, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. 
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | UNC-2025 | 
| Iupac 化学名称 | (1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol  | 
| 同义词 | UNC-2025; UNC2025; UNC 2025  | 
| 英文同义词 | UNC-2025; UNC2025; UNC 2025  | 
| 分子式 | C28H40N6O  | 
| 分子量 | 476.66  | 
| InChiKey |  | 
| InChi |  | 
| Cas号 | 1429881-91-3 | 
| 相关CAS号 |  | 
 
 
| 外观性状 | White solid powder  | 
| 纯度 | 97%  | 
| 存储 | -20 ºC for 3 years  | 
| 可溶性 | Soluble in DMSO  | 
| 处理方式 |  | 
| 运输条件 | Shipped under ambient temperature  | 
| 海关编码 |  | 
 
| Targets |  | 
| Mechanism |  | 
| Cell study |  | 
| Animal study |  | 
| Clinical study |  |